‘Analysing, interpreting and disseminating drug-related data to facilitate decision-making’ will be the focus of an innovative training course hosted by the EU drugs agency (EMCDDA) this week in Lisbon. Opening today and running until 2 October, the event is a thematic twinning initiative of the EU’s Cooperation Programme between Latin America and the European Union on Drugs Policies (COPOLAD).
Čtěte více
The first EMCDDA week on ‘Measuring, understanding and responding to drug problems in Europe’ opens today in Lisbon. The initiative represents a new and integrated take on the usual format of the agency’s five yearly expert meetings, to date dedicated to each of the EMCDDA key epidemiological indicators.
Čtěte více
The EMCDDA welcomes the European Commission’s proposal today to strengthen the EU’s response to new psychoactive substances (‘new drugs’). The proposal follows an unprecedented rise in the number of new drugs detected in Europe in recent years and a Commission review of the EU’s current legal mechanism for monitoring and acting on these new substances.
Čtěte více
International experts convene in Swansea (UK) today to examine the latest scientific research in the rapidly-changing field of new drugs. The Second international conference on novel psychoactive substances is hosted by the College of Human and Health Sciences at Swansea University, in collaboration with Hertfordshire University and the EMCDDA.
Čtěte více
